Stoffel EM, Brand RE, Goggins M (2023) Pancreatic cancer: Changing epidemiology and new approaches to risk assessment, early detection, and prevention. Gastroenterology 164:752–765. https://doi.org/10.1053/j.gastro.2023.02.012
Hu J-X, Zhao C-F, Chen W-B et al (2021) Pancreatic cancer: A review of epidemiology, trend, and risk factors. World J Gastroenterol 27:4298–4321. https://doi.org/10.3748/wjg.v27.i27.4298
Article PubMed PubMed Central Google Scholar
Wood LD, Canto MI, Jaffee EM, Simeone DM (2022) Pancreatic cancer: Pathogenesis, screening, diagnosis, and treatment. Gastroenterology 163:386-402.e1. https://doi.org/10.1053/j.gastro.2022.03.056
Luo W, Tao J, Zheng L, Zhang T (2020) Current epidemiology of pancreatic cancer: Challenges and opportunities. Chin J Cancer Res 32:705
Article CAS PubMed PubMed Central Google Scholar
Aslan M, Shahbazi R, Ulubayram K, Ozpolat B (2018) Targeted therapies for pancreatic cancer and hurdles ahead. Anticancer Res 38:6591–6606. https://doi.org/10.21873/anticanres.13026
Article CAS PubMed Google Scholar
Sarantis P, Koustas E, Papadimitropoulou A et al (2020) Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy. World J Gastrointest Oncol 12:173–181. https://doi.org/10.4251/wjgo.v12.i2.173
Article PubMed PubMed Central Google Scholar
Samanta K, Setua S, Kumari S et al (2019) Gemcitabine combination nano therapies for pancreatic cancer. Pharmaceutics 11:574. https://doi.org/10.3390/pharmaceutics11110574
Article CAS PubMed PubMed Central Google Scholar
Wang X, Lu H, Luo F et al (2024) Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer. J Controlled Release 365:112–131. https://doi.org/10.1016/j.jconrel.2023.11.028
de Sousa CL, Monteiro G (2014) Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer. Eur J Pharmacol 741:8–16. https://doi.org/10.1016/j.ejphar.2014.07.041
Amrutkar M, Gladhaug IP (2017) Pancreatic cancer chemoresistance to gemcitabine. Cancers 9:157. https://doi.org/10.3390/cancers9110157
Article CAS PubMed PubMed Central Google Scholar
Chen D, Liu X, Lu X, Tian J (2023) Nanoparticle drug delivery systems for synergistic delivery of tumor therapy. Front Pharmacol 14:1111991. https://doi.org/10.3389/fphar.2023.1111991
Article CAS PubMed PubMed Central Google Scholar
De Leo V, Maurelli AM, Giotta L, Catucci L (2022) Liposomes containing nanoparticles: preparation and applications. Colloids Surf B Biointerfaces 218:112737. https://doi.org/10.1016/j.colsurfb.2022.112737
Article CAS PubMed Google Scholar
Silli EK, Li M, Shao Y et al (2023) Liposomal nanostructures for Gemcitabine and Paclitaxel delivery in pancreatic cancer. Eur J Pharm Biopharm 192:13–24. https://doi.org/10.1016/j.ejpb.2023.09.014
Article CAS PubMed Google Scholar
Raza F, Evans L, Motallebi M et al (2023) Liposome-based diagnostic and therapeutic applications for pancreatic cancer. Acta Biomater 157:1–23. https://doi.org/10.1016/j.actbio.2022.12.013
Article CAS PubMed Google Scholar
Large DE, Abdelmessih RG, Fink EA, Auguste DT (2021) Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Adv Drug Deliv Rev 176:113851. https://doi.org/10.1016/j.addr.2021.113851
Article CAS PubMed Google Scholar
Subhan MA, Yalamarty SSK, Filipczak N et al (2021) Recent advances in tumor targeting via EPR effect for cancer treatment. J Pers Med 11:571. https://doi.org/10.3390/jpm11060571
Article PubMed PubMed Central Google Scholar
Šturm L, Poklar Ulrih N (2021) Basic methods for preparation of liposomes and studying their interactions with different compounds, with the emphasis on polyphenols. Int J Mol Sci 22:6547. https://doi.org/10.3390/ijms22126547
Article CAS PubMed PubMed Central Google Scholar
Sercombe L, Veerati T, Moheimani F et al (2015) Advances and challenges of liposome assisted drug delivery. Front Pharmacol 6:286. https://doi.org/10.3389/fphar.2015.00286
Article CAS PubMed PubMed Central Google Scholar
Luthuli S, Wu S, Cheng Y et al (2019) Therapeutic effects of fucoidan: A review on recent studies. Mar Drugs 17:487. https://doi.org/10.3390/md17090487
Article CAS PubMed PubMed Central Google Scholar
Moreira ASP, Gaspar D, Ferreira SS et al (2023) Water-soluble saccharina latissima polysaccharides and relation of their structural characteristics with in vitro immunostimulatory and hypocholesterolemic activities. Mar Drugs 21:183. https://doi.org/10.3390/md21030183
Article CAS PubMed PubMed Central Google Scholar
Turrini E, Maffei F, Fimognari C (2023) Ten years of research on fucoidan and cancer: Focus on its antiangiogenic and antimetastatic effects. Mar Drugs 21:307. https://doi.org/10.3390/md21050307
Article CAS PubMed PubMed Central Google Scholar
Lin Y, Qi X, Liu H et al (2020) The anti-cancer effects of fucoidan: a review of both in vivo and in vitro investigations. Cancer Cell Int 20:154. https://doi.org/10.1186/s12935-020-01233-8
Article CAS PubMed PubMed Central Google Scholar
Jin J-O, Yadav D, Madhwani K et al (2022) Seaweeds in the oncology arena: Anti-cancer potential of fucoidan as a drug—a review. Molecules 27:6032. https://doi.org/10.3390/molecules27186032
Article CAS PubMed PubMed Central Google Scholar
Li M, Chen H, Peng D et al (2023) FU-coating pH-sensitive liposomes for improving the release of gemcitabine by endosome escape in pancreatic cancer cells. J Drug Deliv Sci Technol 80:104135. https://doi.org/10.1016/j.jddst.2022.104135
Zheng Z, Peng D, Li M et al (2023) Gemcitabine and Pin1 siRNA co-delivery with fucoidan-coated nano-liposomes for therapy of pancreatic cancer. J Drug Deliv Sci Technol 87:104872. https://doi.org/10.1016/j.jddst.2023.104872
Flórez-Fernández N, Torres MD, González-Muñoz MJ, Domínguez H (2018) Potential of intensification techniques for the extraction and depolymerization of fucoidan. Algal Res 30:128–148. https://doi.org/10.1016/j.algal.2018.01.002
Xiang B, Cao D-Y (2017) Preparation of drug liposomes by thin-film hydration and homogenization. In: Lu W-L, Qi X-R (eds) Liposome-Based Drug Delivery Systems. Springer, Berlin, Heidelberg, pp 1–11
Nagayasu A, Uchiyama K, Kiwada H (1999) The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. Adv Drug Deliv Rev 40:75–87. https://doi.org/10.1016/S0169-409X(99)00041-1
留言 (0)